Mankind Pharma (MANKIND) — Announcement

📢 Key Event
Mankind Pharma receives independent ESG rating of 64 from CRISIL

🔄 What Changed
ESG rating improved from 'Adequate' to 'Strong' and core ESG from 60 to 71

💡 Investor Takeaway
The upgraded ESG rating signals stronger sustainability performance, potentially enhancing investor confidence and long-term value.

Mankind Pharma announced an independent ESG rating of 64 from CRISIL ESG Ratings, up from 57, placing it in the 'Strong' category, with core ESG improving to 71 from 60, reflecting enhanced sustainability performance disclosed for FY2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MANKIND ✨ Ask AI About This

About Mankind Pharma Limited (MANKIND)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹99,077.74 Cr P/E: 48.5 ROE: 12.7% ROCE: 13.9% Div Yield: 0.04%

View full MANKIND stock details →

📡 Get AI alerts when MANKIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANKIND — Free

💡 Ask AI about this filing

"How does this ESG rating compare to peers in the pharma sector?" "What specific initiatives drove the core ESG score improvement?" "Will this rating affect the company's access to capital or borrowing costs?"

Ask AI Free →

📊 More MANKIND filings

See all MANKIND filings →

🔥 Also filed on 22 August 2026

DPSCLTD DPSC Limited Announcement SAMBHV Sambhv Steel Tubes Limited Annual Report BANARISUG Bannari Amman Sugars Limited Annual Report BANARISUG Bannari Amman Sugars Limited Annual Report BCPL BCPL Railway Infrastructure Limited Financial Results LAXMIINDIA Laxmi India Finance Limited Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MANKIND files new disclosures

Track MANKIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANKIND — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd